Daré Bioscience annual meeting results: directors elected, auditor ratified, say-on-pay approved

Dare Bioscience, Inc.

Cheryl R. Blanchard elected with 22,509,430 votes for, 3,095,043 withheld; Sabrina Martucci Johnson with 23,447,732 for, 2,156,741 withheld.
Ratification of Mayer Hoffman McCann as auditor for FY2023: 48,270,018 for, 1,341,227 against, 262,151 abstentions.
Advisory say-on-pay approved: 22,399,824 for, 3,026,516 against, 178,133 abstentions; 24,268,923 broker non-votes.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.98

Dare Bioscience, Inc. shareholders approved Election of Class III directors at the 2023-06-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-21

Exact text from the filing

Each of the director nominees was elected as a Class III director to hold office until our 2026 annual meeting of stockholders, and until a successor is duly elected and qualified, by the votes set forth below.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Dare Bioscience, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2023-06-21 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-21

Exact text from the filing

Our stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement by the votes set forth below.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Dare Bioscience, Inc. shareholders approved Ratification of appointment of Mayer Hoffman McCann P.C. as independent registered public accounting firm at the 2023-06-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-21

Exact text from the filing

Our stockholders ratified the appointment of Mayer Hoffman McCann P.C.as our independent registered public accounting firm for the fiscal year ending December 31, 2023 by the votes set forth below.

View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Dare Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-022075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.